Investors Recent News Jun 25, 2020 Leap Therapeutics Announces Full Exercise of Underwriters' Option to Purchase Additional Shares Jun 22, 2020 Leap Therapeutics Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants Jun 18, 2020 Leap Therapeutics Announces Pricing of $45 Million of Common Stock and Pre-Funded Warrants View All Upcoming Events There are no upcoming events at this time. View All Past Events Apr 23, 2020 at 8:30 AM EDT DKN-01 Gynecologic Cancers Program Update Call & Webcast Mar 4, 2020 at 8:40 AM EST Cowen 40th Annual Health Care Conference Feb 11, 2020 at 11:15 AM EST 22nd Annual BIO CEO & Investor Conference View All
Jun 25, 2020 Leap Therapeutics Announces Full Exercise of Underwriters' Option to Purchase Additional Shares
Jun 22, 2020 Leap Therapeutics Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants
Jun 18, 2020 Leap Therapeutics Announces Pricing of $45 Million of Common Stock and Pre-Funded Warrants
